Acrivon Therapeutics, Inc. Common Stock
$2.10
▼ 0.02
(-0.94%)
Volume: 181,911
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
62
- 21d momentum +1.0%
- MA aligned bullish
- RSI 56
🎯
Pullback
50
- +4.5% vs 20MA
💎
Value
58
- -41% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)55.6
MACD+0.011
MA trendBullish
ATR6.38%
21d mom.+1.0%
63d mom.+25.0%
vs 20MA+4.5%
RVOL(20)0.57×
52w low · 1
52w high · 4
-41.0% from 52-week high
20d support 2
· resistance 2
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$91M
PER—
PBR1.05
PSR—
EPS$-1.73
ROE-85.7%
ROA-74.9%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-0.64
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +13.51% | +0.96% | +25.00% | +47.89% | +34.62% | -14.63% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -1.41%, daily vol 5.33%. Acrivon Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.